|
시장보고서
상품코드
1602020
세계의 페닐케톤뇨증 치료제 시장(2024-2028년)Global Phenylketonuria Treatment Market 2024-2028 |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
페닐케톤뇨증 치료제 시장은 2023-2028년간 3억 3,960만 달러 확대되고, 예측 기간 동안 6.7%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다. 이 보고서는 페닐케톤뇨증 치료제 시장에 대한 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더에 대한 벤더 분석 등의 정보를 전해드립니다.
이 보고서는 현재의 시장 시나리오, 최신 동향 및 성장요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 이 시장은 유전체 연구개발에 대한 투자 증가, PKU 유병률 증가, 파이프라인 의약품의 존재에 의해 주도되고 있습니다.
| 시장 범위 | |
|---|---|
| 기준 연도 | 2024년 |
| 종료 연도 | 2028년 |
| 예측 기간 | 2024-2028년 |
| 성장 모멘텀 | 가속 |
| 전년 대비(2024년) | 6.1% |
| CAGR | 6.7% |
| 증분 금액 | 3억 3,960만 달러 |
이 보고서는 향후 몇 년동안 페닐케톤뇨증 치료제 시장의 성장을 가속하는 주요 요인 중 하나로 공급업체들의 전략적 제휴 증가를 꼽고 있습니다. 또한, 신약 개발 및 상용화의 발전과 의료 산업의 발전은 이 시장에 큰 수요를 창출할 것으로 예상됩니다.
목차
제1장 주요 요약
- 시장 개요
제2장 Technavio의 분석
- 가격 감응도, 수명주기, 고객 구입 바스켓, 채택 비율, 구입 기준 분석
- 인풋의 중요성과 차별화 요인
- 혼란 요인
- 성장 촉진요인과 과제의 영향
제3장 시장 구도
- 시장 생태계
- 시장 특징
- 밸류체인 분석
제4장 시장 규모
- 시장의 정의
- 시장 부문 분석
- 시장 규모(2023년)
- 시장 전망(2023-2028년)
제5장 시장 규모 실적
- 세계의 페닐케톤뇨증 치료 시장(2018-2022년)
- 약제 클래스별 분석(2018-2022년)
- 지역별 분석(2018-2022년)
- 국가별 분석(2018-2022년)
제6장 Five Forces 분석
- Five Forces 요약
- 바이어의 교섭력
- 공급 기업의 교섭력
- 신규 진출업체의 위협
- 대체품의 위협
- 경쟁 위협
- 시장 현황
제7장 시장 세분화 : 약제 클래스별
- 시장 부문
- 비교 : 약제 클래스별
- Sapropterin : 시장 규모와 예측(2023-2028년)
- Pegvaliase-pqpz : 시장 규모와 예측(2023-2028년)
- 시장 기회 : 약제 클래스별
제8장 고객 상황
- 고객 상황 개요
제9장 지역별 상황
- 지역별 세분화
- 지역별 비교
- 북미 : 시장 규모와 예측(2023-2028년)
- 유럽 : 시장 규모와 예측(2023-2028년)
- 아시아 : 시장 규모와 예측(2023-2028년)
- 세계 기타 지역 : 시장 규모와 예측(2023-2028년)
- 미국 : 시장 규모와 예측(2023-2028년)
- 캐나다 : 시장 규모와 예측(2023-2028년)
- 호주 : 시장 규모와 예측(2023-2028년)
- 아일랜드 : 시장 규모와 예측(2023-2028년)
- 멕시코 : 시장 규모와 예측(2023-2028년)
- 핀란드 : 시장 규모와 예측(2023-2028년)
- 중국 : 시장 규모와 예측(2023-2028년)
- 러시아 : 시장 규모와 예측(2023-2028년)
- 인도 : 시장 규모와 예측(2023-2028년)
- 덴마크 : 시장 규모와 예측(2023-2028년)
- 시장 기회 : 지역별
제10장 성장 촉진요인, 과제, 기회 및 성장 억제요인
- 시장 성장 촉진요인
- 시장이 해결해야 할 과제
- 성장 촉진요인과 과제의 영향
- 시장 기회와 성장 억제요인
제11장 경쟁 구도
- 개요
- 경쟁 구도
- 혼란 상황
- 업계 리스크
제12장 경쟁 분석
- 기업 개요
- 기업 순위 지수
- 기업의 시장 포지셔닝
- American Gene Technologies
- BioMarin Pharmaceutical Inc.
- Codexis Inc
- Dr. Schar
- Evox Therapeutics Ltd.
- Homology Medicines Inc.
- Jnana Therapeutics
- Nestle Health Science S.A.
- SOM Innovation Biotech S.A.
- Synlogic Inc.
제13장 부록
LSH 24.12.10Phenylketonuria Treatment Market 2024-2028
The phenylketonuria treatment market is forecasted to grow by USD 339.6 mn during 2023-2028, accelerating at a CAGR of 6.7% during the forecast period. The report on the phenylketonuria treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising investments in genomic research and development, increasing prevalence of pku, and presence of pipeline drugs.
| Market Scope | |
|---|---|
| Base Year | 2024 |
| End Year | 2028 |
| Series Year | 2024-2028 |
| Growth Momentum | Accelerate |
| YOY 2024 | 6.1% |
| CAGR | 6.7% |
| Incremental Value | $339.6 mn |
Technavio's phenylketonuria treatment market is segmented as below:
By Drug Class
- Sapropterin
- Pegvaliase-pqpz
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the rising strategic alliances by vendors as one of the prime reasons driving the phenylketonuria treatment market growth during the next few years. Also, increasing development and commercialization of new drugs and advancements in health care industry will lead to sizable demand in the market.
The report on the phenylketonuria treatment market covers the following areas:
- Phenylketonuria Treatment Market sizing
- Phenylketonuria Treatment Market forecast
- Phenylketonuria Treatment Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading phenylketonuria treatment market vendors that include American Gene Technologies, BioMarin Pharmaceutical Inc., Codexis Inc, Dr. Schar, Evox Therapeutics Ltd., Homology Medicines Inc., Jnana Therapeutics, Nestle Health Science S.A., SOM Innovation Biotech S.A., and Synlogic Inc.. Also, the phenylketonuria treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Drug Class
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
3 Market Landscape
- 3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Market characteristics analysis
- 3.3 Value chain analysis
- Value Chain Analysis
4 Market Sizing
- 4.1 Market definition
- Offerings of companies included in the market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2023
- 4.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)
5 Historic Market Size
- 5.1 Global Phenylketonuria Treatment Market 2018 - 2022
- Historic Market Size - Data Table on Global Phenylketonuria Treatment Market 2018 - 2022 ($ million)
- 5.2 Drug Class segment analysis 2018 - 2022
- Historic Market Size - Drug Class Segment 2018 - 2022 ($ million)
- 5.3 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
- 5.4 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)
6 Five Forces Analysis
- 6.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
- 6.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
- 6.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- 6.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
- 6.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
- 6.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
- 6.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028
7 Market Segmentation by Drug Class
- 7.1 Market segments
- Chart on Drug Class - Market share 2023-2028 (%)
- Data Table on Drug Class - Market share 2023-2028 (%)
- 7.2 Comparison by Drug Class
- Chart on Comparison by Drug Class
- Data Table on Comparison by Drug Class
- 7.3 Sapropterin - Market size and forecast 2023-2028
- Chart on Sapropterin - Market size and forecast 2023-2028 ($ million)
- Data Table on Sapropterin - Market size and forecast 2023-2028 ($ million)
- Chart on Sapropterin - Year-over-year growth 2023-2028 (%)
- Data Table on Sapropterin - Year-over-year growth 2023-2028 (%)
- 7.4 Pegvaliase-pqpz - Market size and forecast 2023-2028
- Chart on Pegvaliase-pqpz - Market size and forecast 2023-2028 ($ million)
- Data Table on Pegvaliase-pqpz - Market size and forecast 2023-2028 ($ million)
- Chart on Pegvaliase-pqpz - Year-over-year growth 2023-2028 (%)
- Data Table on Pegvaliase-pqpz - Year-over-year growth 2023-2028 (%)
- 7.5 Market opportunity by Drug Class
- Market opportunity by Drug Class ($ million)
- Data Table on Market opportunity by Drug Class ($ million)
8 Customer Landscape
- 8.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
- 9.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
- 9.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 9.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
- 9.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 9.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 9.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
- 9.8 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
- 9.9 Australia - Market size and forecast 2023-2028
- Chart on Australia - Market size and forecast 2023-2028 ($ million)
- Data Table on Australia - Market size and forecast 2023-2028 ($ million)
- Chart on Australia - Year-over-year growth 2023-2028 (%)
- Data Table on Australia - Year-over-year growth 2023-2028 (%)
- 9.10 Ireland - Market size and forecast 2023-2028
- Chart on Ireland - Market size and forecast 2023-2028 ($ million)
- Data Table on Ireland - Market size and forecast 2023-2028 ($ million)
- Chart on Ireland - Year-over-year growth 2023-2028 (%)
- Data Table on Ireland - Year-over-year growth 2023-2028 (%)
- 9.11 Mexico - Market size and forecast 2023-2028
- Chart on Mexico - Market size and forecast 2023-2028 ($ million)
- Data Table on Mexico - Market size and forecast 2023-2028 ($ million)
- Chart on Mexico - Year-over-year growth 2023-2028 (%)
- Data Table on Mexico - Year-over-year growth 2023-2028 (%)
- 9.12 Finland - Market size and forecast 2023-2028
- Chart on Finland - Market size and forecast 2023-2028 ($ million)
- Data Table on Finland - Market size and forecast 2023-2028 ($ million)
- Chart on Finland - Year-over-year growth 2023-2028 (%)
- Data Table on Finland - Year-over-year growth 2023-2028 (%)
- 9.13 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
- 9.14 Russia - Market size and forecast 2023-2028
- Chart on Russia - Market size and forecast 2023-2028 ($ million)
- Data Table on Russia - Market size and forecast 2023-2028 ($ million)
- Chart on Russia - Year-over-year growth 2023-2028 (%)
- Data Table on Russia - Year-over-year growth 2023-2028 (%)
- 9.15 India - Market size and forecast 2023-2028
- Chart on India - Market size and forecast 2023-2028 ($ million)
- Data Table on India - Market size and forecast 2023-2028 ($ million)
- Chart on India - Year-over-year growth 2023-2028 (%)
- Data Table on India - Year-over-year growth 2023-2028 (%)
- 9.16 Denmark - Market size and forecast 2023-2028
- Chart on Denmark - Market size and forecast 2023-2028 ($ million)
- Data Table on Denmark - Market size and forecast 2023-2028 ($ million)
- Chart on Denmark - Year-over-year growth 2023-2028 (%)
- Data Table on Denmark - Year-over-year growth 2023-2028 (%)
- 9.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
- 10.4 Market opportunities/restraints
11 Competitive Landscape
- 11.1 Overview
- 11.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 11.3 Landscape disruption
- Overview on factors of disruption
- 11.4 Industry risks
- Impact of key risks on business
12 Competitive Analysis
- 12.1 Companies profiled
- Companies covered
- 12.2 Company ranking index
- Company ranking index
- 12.3 Market positioning of companies
- Matrix on companies position and classification
- 12.4 American Gene Technologies
- American Gene Technologies - Overview
- American Gene Technologies - Product / Service
- American Gene Technologies - Key offerings
- SWOT
- 12.5 BioMarin Pharmaceutical Inc.
- BioMarin Pharmaceutical Inc. - Overview
- BioMarin Pharmaceutical Inc. - Product / Service
- BioMarin Pharmaceutical Inc. - Key offerings
- SWOT
- 12.6 Codexis Inc
- Codexis Inc - Overview
- Codexis Inc - Business segments
- Codexis Inc - Key offerings
- Codexis Inc - Segment focus
- SWOT
- 12.7 Dr. Schar
- Dr. Schar - Overview
- Dr. Schar - Product / Service
- Dr. Schar - Key offerings
- SWOT
- 12.8 Evox Therapeutics Ltd.
- Evox Therapeutics Ltd. - Overview
- Evox Therapeutics Ltd. - Product / Service
- Evox Therapeutics Ltd. - Key offerings
- SWOT
- 12.9 Homology Medicines Inc.
- Homology Medicines Inc. - Overview
- Homology Medicines Inc. - Product / Service
- Homology Medicines Inc. - Key offerings
- SWOT
- 12.10 Jnana Therapeutics
- Jnana Therapeutics - Overview
- Jnana Therapeutics - Product / Service
- Jnana Therapeutics - Key offerings
- SWOT
- 12.11 Nestle Health Science S.A.
- Nestle Health Science S.A. - Overview
- Nestle Health Science S.A. - Product / Service
- Nestle Health Science S.A. - Key offerings
- SWOT
- 12.12 SOM Innovation Biotech S.A.
- SOM Innovation Biotech S.A. - Overview
- SOM Innovation Biotech S.A. - Product / Service
- SOM Innovation Biotech S.A. - Key offerings
- SWOT
- 12.13 Synlogic Inc.
- Synlogic Inc. - Overview
- Synlogic Inc. - Product / Service
- Synlogic Inc. - Key offerings
- SWOT
13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 13.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 13.4 Research methodology
- Research methodology
- 13.5 Data procurement
- Information sources
- 13.6 Data validation
- Data validation
- 13.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 13.8 Data synthesis
- Data synthesis
- 13.9 360 degree market analysis
- 360 degree market analysis
- 13.10 List of abbreviations
- List of abbreviations
샘플 요청 목록